Agios Pharmaceuticals | Créanciers Commerciaux



Trade Creditors Changement Date
AbbVie 2.94B 2.66B 2024-12
Agios Pharmaceuticals USD 13.73M 2.92M 2025-03
Alnylam Pharmaceuticals USD 97.4M 8.98M 2025-03
Amgen USD 2.41B 498M 2025-03
Arrowhead Research USD 9.98M 4.48M 2025-03
Astellas Pharma JPY 187.84B 16.46B 2025-03
AstraZeneca 22.54B 79M 2025-03
Bayer EUR 6.59B 931M 2025-03
Biogen USD 391.5M 32.7M 2025-03
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Bristol-Myers Squibb USD 4B 400M 2025-03
Daiichi Sankyo JPY 564.47B 61.64B 2024-12
Eli Lilly USD 3.44B 213.4M 2025-03
Exelixis USD 42.84M 4.65M 2025-04
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.15B 186M 2025-03
Incyte USD 195.54M 1.93M 2025-03
Ionis Pharmaceuticals USD 17.46M 25.51M 2025-03
Merck USD 3.78B 295M 2025-03
Moderna USD 226M 179M 2025-03
Novartis USD 4.57B 485M 2024-12
Novartis USD 4.57B 485M 2024-12
Pfizer USD 5.24B 393M 2025-03
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Roche Holding 4.35B 828M 2024-12
Sarepta Therapeutics USD 156.1M 58.34M 2025-03
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



Agios Pharmaceuticals Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.